Inactive Instrument

Other languages YM BioSciences Inc.

Equities

YM Biosciences : Raises US$80.5 Million from Public Offering	29/12/29
YM Biosciences : Prices $70 Million Public Offering of Common Shares	24/12/24
YM Biosciences : Announces Proposed Public Offering of Common Shares	24/12/24
YM Biosciences : Reports Operational and Financial Results for the Second Quarter of Fiscal 2012	09/12/09
YM Biosciences : Reports Updated Phase I/II Data for its JAK1/JAK2 Inhibitor CYT387 at ASH 2011	13/11/13
YM Biosciences : Comments on Unusual Market Activity	23/11/23
YM Biosciences : Reports Operational and Financial Results for the First Quarter of Fiscal 2012	11/11/11
YM Biosciences : to Report Updated Phase I/II Data for CYT387 at ASH 2011	07/11/07
YM Biosciences : Nimotuzumab Results Reported at SIOP Conference	31/11/31
YM Biosciences : Initiates Phase II BID Trial with CYT387 in Myelofibrosis	28/11/28
YM Biosciences : CORRECTION FROM SOURCE: YM BioSciences Reports Fiscal 2011 Year End Operational and Financial Results	24/11/24
YM BioSciences Inc. (USA) : Yellowhead Mining Inc. Announces Voting Results of 2011 Annual and Special Meeting	02/11/02
YM BioSciences Inc. (USA) : Yellowhead Mining Inc. Appoints VP Environment, Community & First Nations Relations; Also Manager, Corporate Administration	01/11/01
YM BioSciences Inc. (USA) : YM BioSciences Provides Update on the Development Program for Nimotuzumab	31/11/31

No results for this search